These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5700612)

  • 1. [Experience with the use of niamid in the treatment od depressive states].
    Khivillvitskiĭ TIa; Nuller IuL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1387-90. PubMed ID: 5700612
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some current aspects of antidepressive therapy].
    Predescu V; Vianu I
    Neurol Psihiatr Neurochir; 1967; 12(6):485-94. PubMed ID: 5593224
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 4. [Depressive states in a sanatorium milieu and monoamine oxidase inhibitors. (Therapeutic results by the combination of iproclozide and chlordiazepoxide). Apropos of 146 cases].
    Suerinck A; Suerinck E
    J Med Lyon; 1966 Apr; 47(96):573-86. PubMed ID: 5930723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of depressive states by amitriptyline. Trial of the "drinkable solution" form].
    Pluvinage R
    Sem Hop; 1969 May; 45(22):1560-4. PubMed ID: 4308646
    [No Abstract]   [Full Text] [Related]  

  • 6. MAOA gene polymorphisms and response to mirtazapine in major depression.
    Tzeng DS; Chien CC; Lung FW; Yang CY
    Hum Psychopharmacol; 2009 Jun; 24(4):293-300. PubMed ID: 19382113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination antidepressants are not yet proven therapy in the treatment of depression.
    Olver J; Ellen S; Norman T
    Australas Psychiatry; 2007 Jun; 15(3):248-9. PubMed ID: 17516193
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications and results of the treatment of mental depression by octamoxine (ximaol)].
    Gayral L; Stern H; Puyuelo R
    Therapie; 1966; 21(5):1183-90. PubMed ID: 5976767
    [No Abstract]   [Full Text] [Related]  

  • 10. [Letter: Monoamine oxidase inhibitors].
    Bolwig TG
    Ugeskr Laeger; 1974 Jul; 136(28):1591. PubMed ID: 4407583
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined and selective monoamine oxidase inhibition in the treatment of depression in Parkinson's disease.
    Jansen Steur EN; Ballering LA
    Adv Neurol; 1999; 80():505-8. PubMed ID: 10410764
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relation between glucose tolerance and depression and its therapy using monoamine oxidase inhibitors and lithium salts].
    Pürgyi P
    Nervenarzt; 1972 Jul; 43(7):379-82. PubMed ID: 5047936
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of a new antidepressant inhibitor of monoamine oxidase: R.C. 41.10].
    Lafon R; Minvielle J; Chapel A; Chabanier J
    Therapie; 1966; 21(6):1405-11. PubMed ID: 6002648
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nosological basis and treatment of depressive states].
    Vallet R
    Ann Med Psychol (Paris); 1968 Mar; 1(3):371-401. PubMed ID: 5670012
    [No Abstract]   [Full Text] [Related]  

  • 15. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD; Bodkin JA
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Experience with oxyprothepin in the treatment of endogenous depression.
    Náhunek K; Svestka J; Rodová A; Cesková E; Kulísková O
    Act Nerv Super (Praha); 1975; 17(4):211-2. PubMed ID: 1221758
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychopharmacological dissection of nonendogenous depression.
    Liebowitz MR; Quitkin FM; Stewart JM; McGrath P; Harrison W; Rabkin JG; Klein DF
    Psychopharmacol Bull; 1984; 20(3):390-2. PubMed ID: 6473638
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new MAO inhibitor in the therapy of depressions: MO-1255].
    Herrera JJ; Bauza MA; Nazar J
    Prensa Med Argent; 1967 May; 54(13):591-8. PubMed ID: 5605930
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA; Mesones HL; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Notes on the use of monoamine oxidase inhibitor drugs].
    Gayral L
    Therapie; 1966; 21(5):1175-81. PubMed ID: 5976766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.